{"id":"https://openalex.org/W4385560014","doi":"https://doi.org/10.14283/jpad.2023.96","title":"Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval","display_name":"Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval","publication_year":2023,"publication_date":"2023-08-03","ids":{"openalex":"https://openalex.org/W4385560014","doi":"https://doi.org/10.14283/jpad.2023.96","pmid":"https://pubmed.ncbi.nlm.nih.gov/37874098"},"language":"en","primary_location":{"id":"doi:10.14283/jpad.2023.96","doi":"https://doi.org/10.14283/jpad.2023.96","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2023.96","pdf_url":null,"source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.14283/jpad.2023.96","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081990754","display_name":"Matthew D. Howe","orcid":"https://orcid.org/0000-0002-6373-1535","observed_orcids":["https://orcid.org/0000-0002-6373-1535"]},"institutions":[{"id":"https://openalex.org/I2802060973","display_name":"Butler Hospital","ror":"https://ror.org/00z9zsj19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802060973"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew D. Howe","raw_affiliation_strings":["Dr. Matthew Howe, Butler Hospital Memory and Aging Program, 345 Blackstone Boulevard, Providence, RI 02906, USA, Phone: 401-455-6403, Fax: 401-455-6405, Email: matthew_howe@brown.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Matthew Howe, Butler Hospital Memory and Aging Program, 345 Blackstone Boulevard, Providence, RI 02906, USA, Phone: 401-455-6403, Fax: 401-455-6405, Email: matthew_howe@brown.edu","institution_ids":["https://openalex.org/I2802060973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062410449","display_name":"Karysa J. Britton","orcid":"https://orcid.org/0009-0005-2393-3481","observed_orcids":["https://orcid.org/0009-0005-2393-3481","https://orcid.org/0000-0001-9480-8534"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K.J. Britton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017661375","display_name":"Hannah E. Joyce","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.E. Joyce","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092594462","display_name":"G J Pappas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.J. Pappas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006566763","display_name":"Melanie A. Faust","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.A. Faust","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035721539","display_name":"Brittany C. Dawson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B.C. Dawson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114072139","display_name":"M.C. Riddle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.C. Riddle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002183686","display_name":"Stephen Salloway","orcid":"https://orcid.org/0000-0002-2631-0942","observed_orcids":["https://orcid.org/0000-0002-2631-0942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.P. Salloway","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2890,"currency":"USD","value_usd":2890},"apc_paid":{"value":2890,"currency":"USD","value_usd":2890},"fwci":1.4341,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.80045856,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"10","issue":"4","first_page":"765","last_page":"770"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aducanumab","display_name":"aducanumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/amyloid-related-imaging-abnormalities","display_name":"amyloid-related imaging abnormalities","score":0.9959999918937683},{"id":"https://openalex.org/keywords/aria-e","display_name":"ARIA-E","score":0.7950000166893005},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9079999923706055},{"id":"https://openalex.org/keywords/accelerated-approval","display_name":"accelerated approval","score":0.6140000224113464},{"id":"https://openalex.org/keywords/apoe-epsilon4-carriers","display_name":"APOE \u03b54 carriers","score":0.8360000252723694},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6740000247955322},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.4410000145435333},{"id":"https://openalex.org/keywords/mri-monitoring","display_name":"MRI surveillance","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7358568906784058},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.5185645222663879},{"id":"https://openalex.org/C2777106319","wikidata":"https://www.wikidata.org/wiki/Q362104","display_name":"Institutional review board","level":2,"score":0.44095349311828613},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2804683744907379},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.17660903930664062}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000682","descriptor_name":"Amyloid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.14283/jpad.2023.96","doi":"https://doi.org/10.14283/jpad.2023.96","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2023.96","pdf_url":null,"source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},{"id":"pmid:37874098","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37874098","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of prevention of Alzheimer's disease","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.14283/jpad.2023.96","doi":"https://doi.org/10.14283/jpad.2023.96","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2023.96","pdf_url":null,"source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2023931578","display_name":"Promoting Research Training During Psychiatry Residency","funder_award_id":"R25MH101076","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G9000857910","display_name":"Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease","funder_award_id":"R01AG079241","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G9000916369","display_name":"Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease","funder_award_id":"P01AG051449","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1822779864","https://openalex.org/W2510806376","https://openalex.org/W2752287204","https://openalex.org/W3036604857","https://openalex.org/W3212974917","https://openalex.org/W3217122335","https://openalex.org/W4225741213","https://openalex.org/W4226454711","https://openalex.org/W4310461604","https://openalex.org/W4317434209","https://openalex.org/W4360591479","https://openalex.org/W4360866215","https://openalex.org/W6783925828"],"related_works":["https://openalex.org/W7171850591","https://openalex.org/W7171860266","https://openalex.org/W4390610707","https://openalex.org/W4220777365","https://openalex.org/W4205578634","https://openalex.org/W4389376309","https://openalex.org/W4386324526","https://openalex.org/W3092339972","https://openalex.org/W4210807180","https://openalex.org/W4226454711"],"abstract_inverted_index":{"Aducanumab":[0],"is":[1,11],"the":[2,46,54,61,139,146],"first":[3],"FDA-approved":[4],"amyloid-lowering":[5],"immunotherapy":[6],"for":[7,65],"Alzheimer's":[8],"disease.":[9],"There":[10],"little":[12],"real-world":[13],"data":[14,137],"to":[15,67,142],"guide":[16,68],"management":[17,73],"of":[18,74,82,95],"amyloid-related":[19],"imaging":[20],"abnormalities":[21],"(ARIA),":[22],"a":[23],"potentially":[24],"serious":[25],"side-effect":[26],"which":[27],"requires":[28],"surveillance":[29],"with":[30],"magnetic":[31],"resonance":[32],"imaging.":[33],"We":[34,59],"report":[35],"our":[36],"experiences":[37],"in":[38,41,79,92,100,107,145],"managing":[39],"ARIA":[40,75],"patients":[42],"receiving":[43],"aducanumab":[44,66],"at":[45],"Butler":[47],"Hospital":[48],"Memory":[49],"and":[50,72,104,132],"Aging":[51],"Program":[52],"during":[53],"year":[55],"following":[56],"FDA":[57],"approval.":[58],"followed":[60],"Appropriate":[62,147],"Use":[63,148],"Recommendations":[64],"patient":[69],"selection,":[70],"detection,":[71],"(1).":[76],"ARIA-E":[77],"occurred":[78],"6":[80],"out":[81],"24":[83],"participants":[84,120],"treated;":[85],"all":[86],"APOE-\u03b54":[87],"carriers.":[88],"Treatment":[89],"was":[90],"discontinued":[91],"4":[93],"cases":[94],"moderate-severe":[96],"ARIA-E,":[97],"temporarily":[98],"held":[99],"1":[101,108],"moderate":[102],"case,":[103],"dosed":[105],"through":[106],"mild":[109],"case":[110],"(mean":[111],"duration":[112],"=":[113],"3":[114],"months,":[115],"range,":[116],"1-6":[117],"months).":[118],"No":[119],"required":[121],"hospitalization":[122],"or":[123],"high":[124],"dose":[125],"corticosteroids.":[126],"Participants":[127],"on":[128],"anticoagulation":[129],"were":[130],"excluded":[131],"no":[133],"macrohemorrhages":[134],"occurred.":[135],"These":[136],"support":[138],"measured":[140],"approaches":[141],"treatment":[143],"outlined":[144],"Recommendations.":[149]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-08-04T00:00:00"}